Drug details

Alimta (pemetrexed)

type of Antineoplastics, Antimetabolite

Alimta (pemetrexed) for Injection is a chemotherapy drug indicated for treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer.

This drug may have the following side effects:

• nausea,
• vomiting,
• diarrhea,
• constipation,
• loss of appetite,
• stomach upset,
• tired feeling,
• hair loss, or
• 
  heartburn,
• itching or rash.

The following drugs are related to Alimta, either as a replacement or used together:

• Krazati (adagrasib tablets)
• Tabrecta (capmatinib tablets)
• Cosela (trilaciclib for injection)
• Vizimpro (dacomitinib)
• Taxotere (docetaxel for injection)
• Elzonris (tagraxofusp-erzs injection)
• Rozlytrek (entrectinib capsules)
• Tarceva (erlotinib)
• Exkivity (mobocertinib capsules)
• Gavreto (pralsetinib capsules)
• Iressa (gefitinib)
• Sancuso (granisetron transdermal system)
• Vitrakvi (larotrectinib capsules)
• Lorbrena (lorlatinib tablets)
• Lumakras (sotorasib tablets)
• Zepzelca (lurbinectedin for injection)
• Poteligeo (mogamulizumab-kpkc injection)
• Pemfexy (pemetrexed injection for intravenous use)
• Retevmo (selpercatinib capsules)
• Tepmetko (tepotinib tablets)